Healthcare Industry News: CT colonography
News Release - August 11, 2006
Medicsight Appoints Allan Rowley Chief Financial OfficerLONDON, Aug. 11 (HSMN NewsFeed) -- Medicsight, Inc. (Amex: MGT ), parent company to both Medicsight plc, a leading developer of computer-aided detection (CAD) technologies and software, and Medicexchange.com, an online multi-vendor sales channel for diagnostic, treatment and surgery planning solutions, announced today that Allan Rowley has been appointed Chief Financial Officer and director of the Company. The appointment was effective on August 4, 2006. Mr. Rowley replaces interim CFO and director, Glyn Thomas.
Mr. Rowley most recently served as Finance Director of both Medicsight plc and Medicexchange.com. Prior to joining the Company in April 2006, Mr. Rowley served in a corporate development role at ComMedica Limited, a United Kingdom based medical software company specializing in Picture Archiving & Communication System ("PACS") software. In this role he worked on financing and acquisition opportunities and on commercial proposals with the sales and finance group. Before joining ComMedica, Mr. Rowley was revenue controller and a director of European Finance at Bea Systems, a NASDAQ-listed US-based software company. Mr. Rowley has several years of experience in public accounting in the United Kingdom and United States with Arthur Andersen and Ernst & Young, respectively. He is a member of the Institute of Chartered Accountants in England and Wales and holds a Master of Philosophy and a Bachelor of Science degree from Aberystwyth University College of Wales.
Tim Paterson-Brown, Chief Executive Officer of Medicsight, commented, "We are pleased to have a financial executive of Allan's caliber joining the Medicsight team at this crucial stage in the Company's development. Allan's public company experience and imaging and software industry background will prove to be extremely valuable as we launch Medicexchange.com and begin to grow our revenue base. I look forward to working with him and welcome him to Medicsight."
Mr. Paterson-Brown added, "We thank Glyn Thomas for his excellent service to the Company filling the interim CFO position and we wish him luck in his future endeavors."
About Medicsight, Inc.
Medicsight, Inc. is the parent company to both Medicsight plc, a leading developer of computer-aided detection (CAD) technologies and software, and operator of Medicexchange.com, an online multi-vendor sales channel for diagnostic, treatment and surgery planning solutions. The CAD technology, which is developed by its subsidiary, Medicsight plc, is tested using one of the world's largest databases of verified CT scan data. Medicsight plc's software solutions help clinicians identify, measure, and analyze suspicious pathology, such as colorectal polyps and lung lesions. The company's CAD products include ColonCAD API, the first CAD technology available for CT colonography, and LungCAD API. Medicsight, Inc.'s subsidiary, Medicexchange.com, is an online multi-vendor sales channel for diagnostic, treatment and surgery planning solutions for cardiac, thoracic, orthopedic, women's and abdominal imaging. Medicexchange.com provides these solutions in a low-cost, on-demand and digitally-downloadable format for medical imaging professionals, providing access to information and products that they would traditionally have difficulty accessing. Headquartered in London, Medicsight, Inc. employs more than 60 people and also has offices in the United States, Japan, and China. Product and company information can be found on http://www.medicsight.com. Stock symbol: MGT
All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward- looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.